AllianceBernstein’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-399,290
| Closed | -$27.2M | – | 3381 |
|
|
2022
Q3 | $27.2M | Buy |
399,290
+326,790
| +451% | +$18M | 0.01% | 736 |
|
|
2022
Q2 | $2.32M | Buy |
72,500
+798
| +1% | +$23.4K | ﹤0.01% | 1859 |
|
|
2022
Q1 | $2.48M | Buy |
71,702
+200
| +0.3% | +$5.98K | ﹤0.01% | 1958 |
|
|
2021
Q4 | $2.09M | Sell |
71,502
-1,100
| -2% | -$34.1K | ﹤0.01% | 2120 |
|
|
2021
Q3 | $1.85M | Hold |
72,602
| – | – | ﹤0.01% | 2215 |
|
|
2021
Q2 | $2.54M | Buy |
72,602
+45,267
| +166% | +$1.77M | ﹤0.01% | 2045 |
|
|
2021
Q1 | $1.11M | Sell |
27,335
-10,302
| -27% | -$474K | ﹤0.01% | 2366 |
|
|
2020
Q4 | $1.63M | Sell |
37,637
-154
| -0.4% | -$7.59K | ﹤0.01% | 2098 |
|
|
2020
Q3 | $2.08M | Sell |
37,791
-6,393
| -14% | -$406K | ﹤0.01% | 1825 |
|
|
2020
Q2 | $2.79M | Sell |
44,184
-83,716
| -65% | -$5.74M | ﹤0.01% | 1652 |
|
|
2020
Q1 | $6.53M | Buy |
127,900
+1,100
| +0.9% | +$73.7K | ﹤0.01% | 1068 |
|
|
2019
Q4 | $10.1M | Buy |
126,800
+45,300
| +56% | +$2.68M | 0.01% | 1088 |
|
|
2019
Q3 | $3.95M | Hold |
81,500
| – | – | ﹤0.01% | 1545 |
|
|
2019
Q2 | $4.29M | Buy |
81,500
+7,300
| +10% | +$420K | ﹤0.01% | 1516 |
|
|
2019
Q1 | $3.93M | Buy |
74,200
+900
| +1% | +$44.2K | ﹤0.01% | 1506 |
|
|
2018
Q4 | $3.01M | Hold |
73,300
| – | – | ﹤0.01% | 1594 |
|
|
2018
Q3 | $2.79M | Buy |
73,300
+900
| +1% | +$39.9K | ﹤0.01% | 1708 |
|
|
2018
Q2 | $3.27M | Buy |
72,400
+16,900
| +30% | +$770K | ﹤0.01% | 1564 |
|
|
2018
Q1 | $2.68M | Buy |
55,500
+300
| +0.5% | +$16.7K | ﹤0.01% | 1630 |
|
|
2017
Q4 | $2.17M | Sell |
55,200
-20,000
| -27% | -$747K | ﹤0.01% | 1797 |
|
|
2017
Q3 | $2.33M | Sell |
75,200
-30,000
| -29% | -$844K | ﹤0.01% | 1744 |
|
|
2017
Q2 | $2.88M | Buy |
105,200
+81,500
| +344% | +$2.43M | ﹤0.01% | 1577 |
|
|
2017
Q1 | $873K | Sell |
23,700
-4,800
| -17% | -$121K | ﹤0.01% | 2308 |
|
|
2016
Q4 | $412K | Hold |
28,500
| – | – | ﹤0.01% | 2627 |
|
|
2016
Q3 | $657K | Buy |
28,500
+2,954
| +12% | +$56.3K | ﹤0.01% | 2416 |
|
|
2016
Q2 | $424K | Buy |
+25,546
| New | +$515K | ﹤0.01% | 2572 |
|
|
2016
Q1 | – | Sell |
-26,416
| Closed | -$854K | – | 2942 |
|
|
2015
Q4 | $854K | Buy |
26,416
+8,900
| +51% | +$385K | ﹤0.01% | 2215 |
|
|
2015
Q3 | $738K | Buy |
+17,516
| New | +$826K | ﹤0.01% | 2315 |
|
Other funds holding GBT
AllianceBernstein's GBT Position: Q4 2022 in Review
AllianceBernstein sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 399,290 shares — an estimated $27.2M sold.
AllianceBernstein first reported a position in GBT in Q3 2015 and held it in 28 quarters. The position peaked at $27.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- AllianceBernstein reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- AllianceBernstein sold 399,290 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $27.2M.
- AllianceBernstein first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 28 quarters.
- AllianceBernstein's Global Blood Therapeutics, Inc. position peaked at $27.2M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.